When to Avoid a Restaging Procedure for Non-muscle Invasive Bladder Cancer? Inferences from a Tertiary Care Center

Overview

Journal Indian J Surg Oncol

Specialty Oncology

Date 2022 Oct 3

PMID 36187522

Authors

Deepak Prakash Bhirud

Ankur Mittal

Sunil Kumar

Tushar Aditya Narain

Sanjeev Kishore

Shiv Charan Navriya

Satish Kumar Ranjan

Vikas Kumar Panwar

Affiliations

Soon will be listed here.

Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s13193-022-01516-8.

Citing Articles

Safety, feasibility, and quality of thulium laser en-bloc resection for treatment of non-muscle invasive bladder cancer.

Assem A, Kassem A, Sherif M, Lotfi A, Abdelwahed M Int Urol Nephrol. 2023; 55(12):3103-3109.

PMID: 37639155 PMC: 10611837. DOI: 10.1007/s11255-023-03752-5.

References

Mariappan P, Finney S, Head E, Somani B, Zachou A, Smith G . Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation.... BJU Int. 2011; 109(11):1666-73. DOI: 10.1111/j.1464-410X.2011.10571.x. View

Tseng W, Liu C, Huang S, Liao A, Kuo J, Hun S . Therapeutic benefit of second-look transurethral resection of bladder tumors for newly diagnosed T1 bladder cancer: a single-center experience. Int Urol Nephrol. 2019; 51(8):1335-1342. DOI: 10.1007/s11255-019-02172-8. View

Isharwal S, Konety B . Non-muscle invasive bladder cancer risk stratification. Indian J Urol. 2015; 31(4):289-96. PMC: 4626912. DOI: 10.4103/0970-1591.166445. View

Yuvaraja T, Waigankar S, Bakshi G, Prakash G . Genitourinary cancers: Summary of Indian data. South Asian J Cancer. 2016; 5(3):122-4. PMC: 4991131. DOI: 10.4103/2278-330X.187577. View

Divrik R, Yildirim U, Zorlu F, Ozen H . The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. J Urol. 2006; 175(5):1641-4. DOI: 10.1016/S0022-5347(05)01002-5. View

Soria F, DAndrea D, Moschini M, Giordano A, Mazzoli S, Pizzuto G . Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients?. Urol Oncol. 2019; 38(3):77.e1-77.e7. DOI: 10.1016/j.urolonc.2019.08.010. View

Gotto G, Shea-Budgell M, Ruether J . Low compliance with guidelines for re-staging in high-grade T1 bladder cancer and the potential impact on patient outcomes in the province of Alberta. Can Urol Assoc J. 2016; 10(1-2):33-8. PMC: 4771556. DOI: 10.5489/cuaj.3143. View

Katumalla F, Devasia A, Kumar R, Kumar S, Chacko N, Kekre N . Second transurethral resection in T1G3 bladder tumors - Selectively avoidable?. Indian J Urol. 2011; 27(2):176-9. PMC: 3142825. DOI: 10.4103/0970-1591.82833. View

Gontero P, Sylvester R, Pisano F, Joniau S, Oderda M, Serretta V . The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin. BJU Int. 2015; 118(1):44-52. PMC: 5502757. DOI: 10.1111/bju.13354. View

10.

Rolevich A, Minich A, Nabebina T, Polyakov S, Krasny S, Sukonko O . Surgeon has a major impact on long-term recurrence risk in patients with non-muscle invasive bladder cancer. Cent European J Urol. 2016; 69(2):170-7. PMC: 4986305. DOI: 10.5173/ceju.2016.795. View

11.

Atta M, Kotb A, Sharafeldeen M, Elabbady A, Hashad M . The value of extended good quality transurethral resection of bladder tumour in the treatment of the newly diagnosed bladder cancer. Arab J Urol. 2017; 15(1):60-63. PMC: 5329698. DOI: 10.1016/j.aju.2016.10.003. View

12.

Manoharan V, Mavuduru R, Kumar S, Kakkar N, Devana S, Bora G . Utility of restage transurethral resection of bladder tumor. Indian J Urol. 2018; 34(4):273-277. PMC: 6174718. DOI: 10.4103/iju.IJU_218_17. View

13.

Calo B, Chirico M, Fortunato F, Sanguedolce F, Carvalho-Dias E, Autorino R . Is Repeat Transurethral Resection Always Needed in High-Grade T1 Bladder Cancer?. Front Oncol. 2019; 9:465. PMC: 6558035. DOI: 10.3389/fonc.2019.00465. View

14.

Czech A, Gronostaj K, Frydrych J, Fronczek J, Przydacz M, Wiatr T . Identification of potential prognostic factors for absence of residual disease in the second resection of T1 bladder cancer. Cent European J Urol. 2019; 72(3):252-257. PMC: 6830483. DOI: 10.5173/ceju.2019.1908. View

15.

van Dijk P, Ploeg M, Aben K, Weijerman P, Karthaus H, van Berkel J . Downstaging of TURBT-Based Muscle-Invasive Bladder Cancer by Radical Cystectomy Predicts Better Survival. ISRN Urol. 2011; 2011:458930. PMC: 3197187. DOI: 10.5402/2011/458930. View

16.

Lunney A, Haynes A, Sharma P . Moderate or severe LUTS is associated with increased recurrence of non - muscle - invasive urothelial carcinoma of the bladder. Int Braz J Urol. 2018; 45(2):306-314. PMC: 6541143. DOI: 10.1590/S1677-5538.IBJU.2018.0068. View

17.

Luo S, Lin Y, Zhang W . Does simultaneous transurethral resection of bladder tumor and prostate affect the recurrence of bladder tumor? A meta-analysis. J Endourol. 2010; 25(2):291-6. DOI: 10.1089/end.2010.0314. View

18.

Woldu S, Bagrodia A, Lotan Y . Guideline of guidelines: non-muscle-invasive bladder cancer. BJU Int. 2017; 119(3):371-380. PMC: 5315602. DOI: 10.1111/bju.13760. View

19.

Dwivedi U, Kumar A, Das S, Trivedi S, Kumar M, Sunder S . Relook TURBT in superficial bladder cancer: its importance and its correlation with the tumor ploidy. Urol Oncol. 2008; 27(5):514-9. DOI: 10.1016/j.urolonc.2008.04.015. View

20.

Herr H . The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol. 1999; 162(1):74-6. DOI: 10.1097/00005392-199907000-00018. View